A Single Arm Phase 2 Study to Evaluate Efficacy and Safety of Trastuzumab Deruxtecan for Patients With HER2 Mutant NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
OREIOS International Study
- Status
- COMPLETED
- Phase
- N/A
Compare the Impact of Xuezhikang and Atorvastatin on Glucose Metabolism in Dyslipidemia Patients With Prediabetes
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Assess the Pharmacokinetics of AZD4831 When Administered Alone and in Combination With Itraconazole
- Status
- COMPLETED
- Phase
- PHASE1
GEMINI-NSCLC: NSCLC Biomarker Study
- Status
- RECRUITING
- Phase
- N/A
A Safety Study of AZD4041 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Epidemiology of Thrombotic Thrombocytopenia Syndrome in Integrated Health-care Database in England
- Status
- COMPLETED
- Phase
- N/A
A Global Study to Assess the Effects of Durvalumab With Oleclumab or Durvalumab With Monalizumab Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinic Versus Home Spirometry
- Status
- UNKNOWN
- Phase
- NA
Change in Symptom and Quality of Life in COPD by Budesonide/Glycopyrronium/Formoterol Fumarate Pressurized Metered Dose Inhaler (BGF pMDI)
- Status
- COMPLETED
- Phase
- N/A
Real-World Study on Gene Profile in Patients With Advanced NSCLC Who Progressed on First-Line Osimertinib Therapy(GPS).
- Status
- COMPLETED
- Phase
- PHASE4
Real-World Data of Clinicopathological Characteristics and Management of Breast Cancer Patients According to HER2 Status
- Status
- COMPLETED
- Phase
- N/A
Safety and Preliminary Efficacy Assessment of AZD7789 in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
AZD1656 in Transplantation With Diabetes tO PromoTe Immune TOleraNce
- Status
- COMPLETED
- Phase
- PHASE2
Osimertinib Plus Chemotherapy in Uncommon EGFRm NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations
- Status
- RECRUITING
- Phase
- PHASE3
Short-term Pre-OPerative Durvalumab (MEDI 4736) in Early Small Triple Negative Breast Cancer Patients (POP-Durva)
- Status
- RECRUITING
- Phase
- PHASE2
Acalabrutinib and Rituximab in Elderly Patients With Untreated Mantle Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
REported Outcomes in COPD With Trixeo in Real worlD
- Status
- COMPLETED
- Phase
- N/A
Adavosertib and Gemcitabine in Advanced Pancreatic
- Status
- WITHDRAWN
- Phase
- PHASE2